Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1944 3
1945 94
1946 213
1947 244
1948 298
1949 255
1950 377
1951 885
1952 1162
1953 1134
1954 991
1955 911
1956 889
1957 955
1958 791
1959 668
1960 671
1961 684
1962 404
1963 5
1964 53
1965 963
1966 1446
1967 1512
1968 1556
1969 1611
1970 1573
1971 1511
1972 1401
1973 1428
1974 1498
1975 1372
1976 1506
1977 1529
1978 1570
1979 1639
1980 1645
1981 1594
1982 1784
1983 2012
1984 1957
1985 2010
1986 2278
1987 2348
1988 2491
1989 2634
1990 2834
1991 2745
1992 2921
1993 3073
1994 3144
1995 3498
1996 3692
1997 3716
1998 3951
1999 4153
2000 4333
2001 4627
2002 4740
2003 5348
2004 5588
2005 6044
2006 6603
2007 6629
2008 6822
2009 7058
2010 7723
2011 8457
2012 8978
2013 9827
2014 10530
2015 10901
2016 10419
2017 10397
2018 10517
2019 11066
2020 28373
2021 27028
2022 30753
2023 24488
2024 23408
2025 12702
2026 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

357,861 results

Results by year

Filters applied: . Clear all
Page 1
Nintedanib in children and adolescents with fibrosing interstitial lung diseases.
Deterding R, Young LR, DeBoer EM, Warburton D, Cunningham S, Schwerk N, Flaherty KR, Brown KK, Dumistracel M, Erhardt E, Bertulis J, Gahlemann M, Stowasser S, Griese M; InPedILD trial investigators. Deterding R, et al. Eur Respir J. 2023 Feb 2;61(2):2201512. doi: 10.1183/13993003.01512-2022. Print 2023 Feb. Eur Respir J. 2023. PMID: 36041751 Free PMC article. Clinical Trial.
Redefining ARDS: a paradigm shift.
Villar J, Szakmany T, Grasselli G, Camporota L. Villar J, et al. Crit Care. 2023 Oct 31;27(1):416. doi: 10.1186/s13054-023-04699-w. Crit Care. 2023. PMID: 37907946 Free PMC article. Review.
Rituximab and mycophenolate mofetil combination in patients with interstitial lung disease (EVER-ILD): a double-blind, randomised, placebo-controlled trial.
Mankikian J, Caille A, Reynaud-Gaubert M, Agier MS, Bermudez J, Bonniaud P, Borie R, Brillet PY, Cadranel J, Court-Fortune I, Crestani B, Debray MP, Gomez E, Gondouin A, Hirschi-Santelmo S, Israel-Biet D, Jouneau S, Juvin K, Leger J, Kerjouan M, Marquette CH, Naccache JM, Nunes H, Plantier L, Prevot G, Quetant S, Traclet J, Valentin V, Uzunhan Y, Wémeau-Stervinou L, Bejan-Angoulvant T, Cottin V, Marchand-Adam S; EVER-ILD investigators and the OrphaLung network. Mankikian J, et al. Eur Respir J. 2023 Jun 8;61(6):2202071. doi: 10.1183/13993003.02071-2022. Print 2023 Jun. Eur Respir J. 2023. PMID: 37230499 Free article. Clinical Trial.
Senotherapy for lung diseases.
Barnes PJ. Barnes PJ. Adv Pharmacol. 2023;98:249-271. doi: 10.1016/bs.apha.2023.04.001. Epub 2023 Apr 20. Adv Pharmacol. 2023. PMID: 37524489
Oxygen therapy and interstitial lung disease.
Sørensen SR, Bendstrup E, Davidsen JR. Sørensen SR, et al. Ugeskr Laeger. 2022 Nov 14;184(46):V05220307. Ugeskr Laeger. 2022. PMID: 36426814 Free article. Review. Danish.
357,861 results
You have reached the last available page of results. Please see the User Guide for more information.